Holding(s) in Company

RNS Number : 4615C
Dechra Pharmaceuticals PLC
01 May 2012
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Dechra Pharmaceuticals Plc

GB0009633180

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

YES

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights


 

Other (please specify):

 


 

3. Full name of person(s) subject to the notification obligation:

 

 

UBS Investment Bank

4. Full name of shareholder(s) (if different from 3.):

 

 

UBS AG London Branch

5. Date of the transaction and date on which the threshold is crossed or reached:

 

 

26th April 2012

6. Date on which issuer notified:

 

 

30th April 2012

7. Threshold(s) that is/are crossed or reached:

 

 Below Notifiable Threshold

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB0009633180

2,144,393

2,144,393

 Below Notifiable Threshold

Below Notifiable Threshold

Below Notifiable Threshold

Below Notifiable Threshold

Below Notifiable Threshold


 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 






Nominal

Delta

 



 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 Below Notifiable Threshold

 Below Notifiable Threshold

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 


11. Number of voting rights proxy holder will cease to hold:

 


12. Date on which proxy holder will cease to hold voting rights:

 


 

13. Additional information:

 


14. Contact name:

 

 

Konstantina Georgaki / Zuzana Gorogova

15. Contact telephone number:

 


+41 44 239 6225

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMGGKLMMGZZG
UK 100

Latest directors dealings